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Fungal infections are affecting millions of people in the world every year. Severity of infections range from superficial 
mycoses to more chronic systemic mycoses. As more fungi species evolve, emergence of drug resistant strains is 
becoming a serious concern to the public health. There is now less number of effective antifungal drugs available in the 
market for treatment of invasive fungal infections. In an effort to combat this escalating issue, the use of nanoparticles as 
antifungal agent has been proposed and explored. Versatility of nanoparticles and its unique physico-chemical properties 
are proven beneficial for developing new therapeutic methods in treatment of fungal infections. Nanoparticles produced 
from biological synthesis have attracted keen interests from researchers, as they are more environmentally friendly, 
sustainable, cost-effective, and biocompatible. This mini review will provide an insight on the current antifungal studies 
and discuss the theory behind mechanism of actions of nanoparticles.  
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1. Introduction 
Fungi are abundant group of organisms that can be found in a wide range of habitats 
around the world including forests, deserts, deep in the ocean as well as polar regions [1]. 
There are about 250,000 types of fungi species currently known worldwide. Most of the fungi 
play important roles in the ecosystems especially in the degradation process of organic 
matters [1, 2]. Besides that, fungi are considered essential towards human population as 
various drugs and enzymes are often derived from them. Nevertheless, about 300 types of 
fungi have been categorized as potentially pathogenic or true pathogens as they can cause 
infections in living things including humans, animals and plants [2].  
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Infection of fungi in humans can range from superficial, only affecting skin, to more 
severe systemic mycoses which can damage internal organs, leading to death in the worst 
case scenario [3]. These fungal infections can be classified into four types; superficial 
mycoses, cutaneous mycoses, subcutaneous mycoses and systemic mycoses [2]. Superficial 
mycoses are the most common fungal infections, affecting about 25% of human population. 
They can spread and grow to other skin regions, is contagious to other people, and can cause 
secondary bacterial infections, further decreasing host’s quality of life [3]. While superficial, 
cutaneous and subcutaneous mycoses are rarely life threatening and still manageable with 
antifungal drugs, the same cannot be said for systemic mycoses. Every year, millions of 
people are diagnosed with the invasive fungal infections and require extensive therapy as 
well as long-term hospitalization. Systemic mycoses are usually associated with high 
morbidity and mortality rate, limited and expensive antifungal therapy options, long periods 
of treatment and drug toxicity [4]. Compared to healthy individuals, those who are 
immunocompromised are at a higher risk of opportunistic infections by pathogenic fungi 
due to their suppressed immune system. A few high-risk groups include HIV/AIDS patients, 
transplant patients, and cancer patients who are undertaking immunosuppressive therapy.  
Examples of chronic, widespread systemic mycoses are candidiasis, cryptococcosis and 
aspergillosis typically caused by Candida, Cryptococcus and Aspergillus species, respectively. 
Candida spp. are ubiquitous and commonly found on human mucosal surfaces such as the 
gastrointestinal and urogenital tracts. They are a part of the human microbiota (commensal) 
but can readily become pathogenic under certain conditions such as immunosuppression, or 
when there are changes in the normal microbial flora [5]. The most prominent species usually 
found causing infections in humans is C. albicans. Other than that, infections by C. auris 
species have been garnering concern from healthcare professionals for its multidrug-
resistance properties. In addition, Candida spp. are notorious for their ability to form biofilm, 
in order to provide the fungal cells extra protection from host immune system. This defense 
mechanism also often results in further increase of drug resistance, making it more 
complicated to treat, resulting in mortality rates as high as 41% [5]. Currently, three 
antifungal drugs; polyenes, azoles and echinocandins are mainly used in the treatment of 
invasive candidiasis but their effectiveness against biofilms vary [4]. Next, cryptococcosis is 
an infection by C. neoformans/C. gatii species complexes [4]. These opportunistic fungal 
pathogens will then cause patients to develop pneumonia and/or meningitis especially in 
immunocompromised hosts. Lastly, aspergillosis mostly involves the lungs and paranasal 
sinuses, inducing an allergic-like reaction in hosts. 90% of the invasive infections are caused 
by A. fumigatus species, which are also abundant in various environments. A. fumigatus is 
said to have azole drug resistance, making it an emerging threat to the healthcare system [4].  
Throughout the years, increasing reports of multidrug resistant fungi species have been 
reported as they evolve with time. Decreasing number of effective antifungal drugs are now 
available for treatment, forcing us to limit the dosage and frequency of these drugs resulting 
in lower efficacy and even therapeutic failure [2]. At the same time, we still have to face 
challenges with negative side effects and toxicity of these drugs towards patients. To combat 
these alarming issues, there is a need to develop more efficient therapeutic methods with 
improved efficacy, allows for targeted delivery of drugs to reduce toxicity and side effects, 
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lower dosage requirement, as well as suitable production costs [4]. Since the new therapy 
methods are likely to demonstrate different mechanism of action, they might work 
synergistically with existing drugs to achieve better response [3].  
Nanotechnology has risen as a preferred field in the pharmaceutical formulations for new 
antifungal therapeutics due to its ability to alter the physico-chemical properties of 
synthesized drugs. Specifically, various types of nanoparticles have been studied for their 
potential in becoming efficient antifungal agent. Nanoparticles are mainly employed due to 
their versatility as we can make use of their intrinsic antifungal activity or utilize them as 
drug delivery vehicles [4]. By using nanoparticles, a lot of major obstacles of current 
antifungal agents such as low drug stability, poor pharmacokinetic, limited penetration 
through the tissues, low solubility and high toxicity can be overcome [2]. Hence, 
development of nanoparticles as antifungal agents is a promising strategy to improve 
therapeutic efficacy and minimize adverse effects of current drugs towards systemic mycoses 
patients [1]. This mini review will be focusing on biologically synthesized nanoparticles, their 
antifungal activities and mechanism of actions.   
 
2. Biological synthesis of nanoparticles 
Typically, there are two means for nanoparticles synthesis; top-down approach and 
bottom-up approach. In top-down approach, nanoparticles are produced after breaking 
down process of larger materials using physical synthesis such as ultrasonication, and 
thermal decomposition. Procedure using physical synthesis usually requires high amount of 
energy, advanced laboratory equipment for electronic excitation and it can be quite 
expensive. On the other hand, bottom-up approach refer to the nanometric structure built up 
from atomic and molecular components [6]. This approach comprises of chemical and 
biological synthesis. A few examples of chemical synthesis methods are vapor flux 
condensation, electrochemistry and chemical reduction [6]. The main drawback of chemical 
synthesis is the use of highly toxic chemicals that are detrimental to the environment and 
human health when released as by-products [7].  
Biological synthesis refers to the exploitation of plant materials or microbes during the 
fabrication process of nanoparticles. Plant materials contain abundant organic compounds 
such as phenolic compounds, alkaloids and terpenoids [6]. Similarly, microbes can also 
produce beneficial biomolecules like enzymes, proteins and secondary metabolites [6]. These 
compounds can function as a reducing agent and/or stabilizer to assist in the production of 
size-controlled and stable nanoparticles. Table 1 shows a list of biologically synthesized 
nanoparticles for antifungal studies in recent years. Biological synthesis is a facile, cost-
effective and sustainable method compared to other synthesis methods. Apart from that, it 
has lower toxicity and is more environmentally friendly as less hazardous by-products are 
released into the nature, since none or minimal toxic chemicals are used. Due to these 
reasons, biological synthesis can be easily scaled up for industrial use.  
Antimicrobial activities of nanoparticles are directly related to their physico-chemical 
properties for instance size, shape, surface area, solubility, aggregation and type of coating 
[4]. Therefore, it is vital to control the method and conditions of formulation in order to 
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produce nanoparticles with specific characteristics. By altering reaction parameters such as 
temperature, type of reducing agent/stabilizers, concentration and nature of solvent, 
significant changes can be observed on the synthesized nanoparticles [7].  
  
Table 1: Nanoparticles synthesized from various biological sources for use in antifungal 
studies. 
No. Sample Biological source Size 
(nm) 
Target fungi Ref. 
1. TiO2 
NPs 
Biomass of Trianthema 
portulacastrum and Chopodium 
quinoa 
6-8 Ustilago tritici [8]  
2. Ag NPs Microwave irradiation with 
Ziziphus jujuba Mill fruit 
extract 
8 Aspergillus niger 
Aspergillus fumigatus 
[9] 
3. Ag NPs Green alga (Scenedesmus 


























6. Ag NPs Plantago major seeds extract 10-39 Penicillium digitatum [13]  
7. Ag-Au 
NPs 
Triple helix glucan (Lentinan) 
polysaccharide 















10. IO NPs Rhamnella gilgitica leaves 
extract 
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3. Antifungal activities and mechanisms of nanoparticles  
The interdisciplinary studies of nanotechnology and biomedicine has opened the door to 
more exciting research possibilities and allowed valuable insights into molecular biology 
[18]. Over the last few years, a wide range of nanoparticles have been synthesized using 
various biological resources for antifungal studies. Examples include silver (Ag), zinc oxide 
(ZnO), titanium dioxide (TiO2), copper oxide (CuO) and iron oxide (IO) nanoparticles. 
Antifungal studies using these nanoparticles have revealed great potential and excellent 
fungicidal activities against a broad range of fungi species. In particular, human infecting 
fungi species such as C. albicans, C. tropicalis, and A. niger have been extensively investigated. 
Supplementary to that, there are also a decent number of antifungal studies against 
phytopathogens such as U. tritici and F. oxysporum.  
One of the most widely discussed antimicrobial mechanism of nanoparticles is the 
reactive oxygen species (ROS)-induced oxidative stress. Upon interaction with nanoparticles, 
levels of intracellular ROS such as hydroxyl radical (OH), superoxide radical (O-), and 
hydrogen peroxide will increase excessively, inducing destructive effects towards fungi 
cellular components (lipids, DNA, and proteins), subsequently causing apoptosis [6].  
 
 
Fig. 1. Antifungal mechanism of actions of nanoparticles. 
 
Another major mode of action is the release of metal ions from nanoparticles after 
crossing the cell interstitium. Due to charge difference, the metal ions will cause destruction 
to the fungal cell wall by inactivation of sulfhydryl group [10]. This in turn leads to leakage 
of cellular content such as disruption of membrane bound enzymes and lipids, which ends 
with pathogen death [4]. Besides that, since nanoparticles are small in size, it has larger 
Journal of Research in Nanoscience and Nanotechnology  
Volume 1, Issue 1 (2021) 22-29 
27 
 
surface area which allows more molecules to be exposed, increasing damage. The antifungal 
mechanism of nanoparticles is illustrated as shown in Figure 1.  
To increase the efficacy of their nanoparticles, some researchers opt to modification of the 
nanoparticles with certain compounds. For instance, a research by Noura et al. investigated 
the antimicrobial activities of Ag NPs modified with chitosan derivatives [16]. Results of the 
antifungal activities proved that combination of Ag NPs with chitosan were more potent 
compared to virgin chitosan. This highlights the importance of choosing the right material 
for nanoparticles alteration to enhance their antimicrobial properties. In the published report, 
chitosan was chosen as it is well known to inhibit spores germination, elongation of fungal 
tubes and growth of radials [16]. It is mentioned that nanoparticles modification might 
increase the susceptibility of fungal cell walls, leading to easier uptake of chitosan-Ag NPs 
which then disturb cell functions ultimately causing death [16].  
Since fungi species are known to form biofilms, a moderate amount of antibiofilm studies 
have also been conducted in the last few years. A study by Xuewei et al. shows results 
indicated that nanomaterial could significantly inhibit the formation of biofilms in a dose-
dependent manner [14]. Similar findings can also be observed in a paper by Tanmoy et al. 
showing Ag NPs fungicidal (MFC) values of around 10.7 ug/mL to 21.4 ug/mL for four 
different Candida species and their biofilm counterparts [12]. These studies are very 
important as treating biofilms is more challenging due to their tough structure and high drug 
resistance. From all these published results, it can be concluded that therapies using 
biologically synthesized nanoparticles could potentially be developed as antifungal agents 
in the near future.  
4. Conclusions 
Even though fungal infections are common, it is often overlooked as it rarely becomes 
life-threatening for healthy people. However, for immunocompromised patients, treating 
fungal infections can become complicated especially with the rise of multidrug resistant 
fungi strains and limited number of antifungal drugs available for use. There is an urgent 
need for new therapeutic methods to solve these problems before it becomes worse. 
Nanoparticles have been presented as a promising solution for these issues as it can enhance 
treatment effectiveness and reduce side effects during prolonged therapies. Nanoparticles 
can also be coupled with existing drugs for more synergistic results in an effort to overcome 
multidrug resistance problem. Since there is increasing awareness on environmental issues 
nowadays, biological synthesis of nanoparticles can be carried out to minimize harm and 
reduce toxic chemicals. By combining all these interdisciplinary knowledge together, more 
practical, effective, and safe therapeutic methods can be designed using biologically 
synthesized nanoparticles for antifungal applications.  
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